 |
ArchiveFilings Reveal Holdings of Quant Fund Black Box (AAPL, GE, TGT, XOM, INTC, MCD, PCLN, LLY, ALTR, JNJ, KO)Posted by Jason Smith at 9:42AM on May 23rd
Notable quant fund Renaissance Technologies is reportedly seeing better results of late. James Simons’ flagship Medallion Fund continues to post eye-popping numbers year after year, averaging 45% since the fund’s inception in 1988 through 2010, according to Reuters. The firm’s…  U.S. Debt Rating Change Sends Stocks Tumbling (C, HAL, LLY, GWW, AMRN, PLUG)Posted by Geoff Seiler at 4:48PM on April 18th
Stocks tumbled after S&P put U.S. debt on negative credit watch, with the ratings agency saying that it has little confidence that the government will be able to come up with a deficit-reduction plan before the next election in 2012.… Yield Hunter: Dividends on the Move (PFE, AZN, BMY, GSK, LLY, IRM, CSC, ACN, IBM, GE)Posted by Ryan Patel at 9:01AM on December 14th
Pharmaceutical giant Pfizer (PFE) is ramping up its dividend after the firm’s board declared a 20-cent first-quarter 2011 dividend on the company’s common stock, payable March 1, 2011, to shareholders of record at the close of business on February 4, 2011.… Boring Sector Offering High-Income Plays (GSK, LLY, AZN, BMY, PFE)Posted by Ryan Patel at 9:36AM on December 6th
The market staged a strong rally over the past week, but not every sector has followed suit. And while major pharmaceutical stocks aren’t typically thought of as high-yielding plays, the segment’s underperformance has taken down prices of some names in… Merck Hikes Diabetes Exposure Via Acquisition (MRK, JNJ, DEPO, ARRY, MNKD, SPEX, BIOD, AMLN, GNBT, ALKS, LLY, ARNA)Posted by Jason Smith at 11:39AM on December 2nd
Pharmaceutical giant Merck (MRK) agreed to purchase Beverly, Massachusetts-based insulin maker SmartCells for as much as $500 million, boosting the firm’s exposure the diabetes segment, which generated $2.58 billion in 2009 revenue. Miller Tabak portfolio manager Les Funtleyder told Bloomberg, “We… Pro Picks In Big Pharma Paying Big Dividends (JNJ, BRK.A, PFE, ABT, MRK, LLY, GSK, BRK.B)Posted by Jason Smith at 2:36PM on August 24th
In the pharmaceutical space, Johnson & Johnson (JNJ) is far and away the Pros’ favorite U.S.-listed equity play based on aggregate inclusion in the top holdings of 13F-filing asset managers. At the end of the second quarter, 794 Pros held the stock… Spotting High-Yields in Big Pharma (AZN, LLY, GSK, PFE, JNJ)Posted by Ryan Patel at 9:43AM on August 17th
When investors think of high yielding sectors, typically the healthcare and major drugs segment doesn’t come to mind. However, with broad benchmarks still off nearly -4% over the last week, several names in the big pharma space have gone along… Big Pharma Paying Healthy Dividends (PFE, MRK, JNJ, GSK, LLY, WCRX, RHHBY)Posted by Owen Vater at 9:55AM on August 6th
Last year Pfizer (PFE) slashed its dividend to help finance the firm’s Wyeth buyout, but according to the company’s remarks on a conference call earlier this week, it plans to hike the payout ratio to about 40% of net income in… Big Yields in Big Pharma (BMY, AZN, LLY, GSK, JNJ, PFE, ABT, BAX, NVO)Posted by Ryan Patel at 11:38AM on June 14th
When investors think of high yielding sectors, typically the healthcare and major drugs segment doesn’t come to mind. However, the recent broader market decline from April’s highs has taken down prices of some names in the space, giving investors the… Good News for Big Pharma at ASCO (BMY, NVS, BAX, SNY, WCRX, AMGN, LLY, PFE)Posted by Sue Miller at 7:26AM on June 7th
Results are out from the American Society of Clinical Oncology (ASCO) conference, which featured trial results from big-cap pharma companies for revolutionary treatments for leukemia, skin and lung cancers. Bristol-Myers Squibb (BMY) is expected to open higher on Monday morning after positive…  |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |